查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1540877

2024-2032 年按類型、藥物類別、配銷通路、最終用戶和地區分類的出血性疾病治療市場報告

Bleeding Disorders Treatment Market Report by Type, Drug Class, Distribution Channel, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球出血性疾病治療市場規模達150億美元。

出血性疾病包括血友病 A 和 B、馮維勒布蘭氏症、特發性血小板減少性紫斑症 (ITP) 以及維生素 K 和因子 II、V、VII、X 和 XII 缺乏症。它們是一類破壞個體血液凝固過程的疾病。它們還可能導致受傷後大量且長時間的出血。她們的症狀包括經血過多、容易瘀青、經常流鼻血、小傷口出血過多、關節出血。透過全血球計數 (CBC)、血小板聚集和出血時間的血液檢查來診斷。他們的治療包括藥物治療，包括腎上腺素縮氨基脲、視網膜出血、鼻出血、氨基己酸、抑肽酶和鐵補充劑。這些藥物可以幫助減少特定症狀並延長患者的生命。出血性疾病的治療還包括輸血、替代療法以及注射凝血因子和血漿。

出血性疾病治療市場趨勢：

出血性疾病在大眾中的盛行率不斷上升，以及老年人口的增加（更容易受到這些疾病的影響）是推動全球市場的關鍵因素之一。此外，擴大採用為出血性疾病治療提供經濟援助並減少醫療費用的健康保險政策，正在對市場產生積極影響。此外，許多國家的管理機構正在提高人們對血液和血漿捐贈的認知。他們也採取措施來推廣捐血營。除此之外，人們對有效治療替代方案的認知不斷增強，正在為市場創造積極的前景。此外，研發（R＆D）活動以及醫療保健基礎設施和診斷技術的顯著改進預計將為市場提供良好的前景。

本報告回答的關鍵問題：

  • 迄今為止，全球出血性疾病治療市場的表現如何？
  • COVID-19 對全球出血性疾病治療市場有何影響？
  • 主要區域市場有哪些？
  • 依類型分類市場是怎麼樣的？
  • 根據藥物類別分類的市場是怎麼樣的？
  • 基於配銷通路的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球出血性疾病治療市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球出血性疾病治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 甲型血友病
    • 市場趨勢
    • 市場預測
  • 乙型血友病
    • 市場趨勢
    • 市場預測
  • 血管性血友病
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依藥物類別

  • 血漿衍生凝血因子濃縮物
    • 市場趨勢
    • 關鍵環節
      • 因子VIII
      • 因子IX
      • 馮維勒布蘭氏症的因素
      • 活化凝血酶原複合物濃縮物
    • 市場預測
  • 重組凝血因子濃縮物
    • 市場趨勢
    • 關鍵環節
      • 因子VIII
      • 馮維勒布蘭氏症的因素
      • 因子IX
    • 市場預測
  • 去氨加壓素
    • 市場趨勢
    • 市場預測
  • 抗纖溶藥
    • 市場趨勢
    • 市場預測
  • 纖維蛋白密封劑
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥局
    • 市場趨勢
    • 市場預測
  • 網路商店
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院
    • 市場趨勢
    • 市場預測
  • 診所
    • 市場趨勢
    • 市場預測
  • 學術及研究機構
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc
    • Alnylam Pharmaceuticals Inc.
    • Bayer AG
    • CSL Behring (CSL Limited)
    • Grifols SA
    • Johnson & Johnson
    • Novo Nordisk A/S
    • Octapharma AG
    • Pfizer Inc.
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
    • Wellona Pharma
Product Code: SR112024A6567

The global bleeding disorders treatment market size reached US$ 15.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.12% during 2024-2032.

Bleeding disorders involve hemophilia A and B, Von Willebrand disease, idiopathic thrombocytopenic purpura (ITP), and deficiencies of vitamin K and factors II, V, VII, X, and XII. They are a class of conditions that disrupt the blood clotting process in an individual. They can also lead to heavy and prolonged bleeding after an injury. They have symptoms, including heavy menstrual bleeding, easy bruising, frequent nosebleeds, excessive bleeding from minor cuts, and joint bleeding. They are diagnosed through blood tests of complete blood count (CBC), platelet aggregation, and bleeding time. Their treatment comprises medications, including adrenochrome monosemicarbazone, retinal hemorrhage, epistaxis, aminocaproic acid, aprotinin, and iron supplements. These medications can aid in minimizing specific symptoms and prolonging the life of patients. Bleeding disorders treatment also includes blood transfusion, replacement therapy, and injections of a clotting factor and plasma.

Bleeding Disorders Treatment Market Trends:

The increasing prevalence of bleeding disorders among the masses and the rising geriatric population, which is more susceptible to these medical conditions, are among the key factors driving the market around the world. Moreover, the growing adoption of health insurance policies that provide financial assistance for bleeding disorders treatment and reduce healthcare expenses is influencing the market positively. In addition, governing agencies of numerous countries are generating awareness about blood and plasma donation. They are also undertaking initiatives to promote blood donation camps. Apart from this, the increasing awareness about the availability of effective treatment alternatives is creating a positive outlook for the market. Furthermore, research and development (R&D) activities and considerable improvements in the healthcare infrastructure and diagnostic technologies are expected to provide a favorable outlook to the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bleeding disorders treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug class, distribution channel and end user.

Breakup by Type:

Hemophilia A

Hemophilia B

Von Willebrand Disease

Others

Breakup by Drug Class:

Plasma-derived Coagulation Factor Concentrates

Factor VIII

Factor IX

Factor for Von Willebrand Disease

Activated Prothrombin Complex Concentrate

Recombinant Coagulation Factor Concentrates

Factor VIII

Factor for Von Willebrand Disease

Factor IX

Desmopressin

Antifibrinolytics

Fibrin Sealants

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Stores

Breakup by End User:

Hospitals

Clinics

Academic and Research Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc, Alnylam Pharmaceuticals Inc., Bayer AG, CSL Behring (CSL Limited), Grifols S.A., Johnson & Johnson, Novo Nordisk A/S, Octapharma AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Wellona Pharma.

Key Questions Answered in This Report:

  • How has the global bleeding disorders treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global bleeding disorders treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global bleeding disorders treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bleeding Disorders Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Hemophilia A
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hemophilia B
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Von Willebrand Disease
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Plasma-derived Coagulation Factor Concentrates
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Factor VIII
      • 7.1.2.2 Factor IX
      • 7.1.2.3 Factor for Von Willebrand Disease
      • 7.1.2.4 Activated Prothrombin Complex Concentrate
    • 7.1.3 Market Forecast
  • 7.2 Recombinant Coagulation Factor Concentrates
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Factor VIII
      • 7.2.2.2 Factor for Von Willebrand Disease
      • 7.2.2.3 Factor IX
    • 7.2.3 Market Forecast
  • 7.3 Desmopressin
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Antifibrinolytics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Fibrin Sealants
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Alnylam Pharmaceuticals Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CSL Behring (CSL Limited)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Grifols S.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novo Nordisk A/S
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Octapharma AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Takeda Pharmaceutical Company Limited
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Wellona Pharma
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Bleeding Disorders Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Bleeding Disorders Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Bleeding Disorders Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Bleeding Disorders Treatment Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Bleeding Disorders Treatment Market: Breakup by Drug Class (in %), 2023
  • Figure 6: Global: Bleeding Disorders Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Bleeding Disorders Treatment Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Bleeding Disorders Treatment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Bleeding Disorders Treatment (Hemophilia A) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Bleeding Disorders Treatment (Hemophilia A) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Bleeding Disorders Treatment (Hemophilia B) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Bleeding Disorders Treatment (Hemophilia B) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Bleeding Disorders Treatment (Von Willebrand Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Bleeding Disorders Treatment (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Bleeding Disorders Treatment (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Bleeding Disorders Treatment (Plasma-derived Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Bleeding Disorders Treatment (Recombinant Coagulation Factor Concentrates) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Bleeding Disorders Treatment (Desmopressin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Bleeding Disorders Treatment (Desmopressin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Bleeding Disorders Treatment (Antifibrinolytics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Bleeding Disorders Treatment (Fibrin Sealants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Bleeding Disorders Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Bleeding Disorders Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Bleeding Disorders Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Bleeding Disorders Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Bleeding Disorders Treatment (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Bleeding Disorders Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Bleeding Disorders Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Bleeding Disorders Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Bleeding Disorders Treatment (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Bleeding Disorders Treatment (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Bleeding Disorders Treatment (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia-Pacific: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia-Pacific: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Bleeding Disorders Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Bleeding Disorders Treatment Market: Breakup by Country (in %), 2023
  • Figure 89: Middle East and Africa: Bleeding Disorders Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Global: Bleeding Disorders Treatment Industry: SWOT Analysis
  • Figure 91: Global: Bleeding Disorders Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Bleeding Disorders Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bleeding Disorders Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 4: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Bleeding Disorders Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Bleeding Disorders Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Bleeding Disorders Treatment Market: Competitive Structure
  • Table 8: Global: Bleeding Disorders Treatment Market: Key Players